Chenqi Lu
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Circular RNAs in diseases
- Pluripotent Stem Cells Research
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- CRISPR and Genetic Engineering
Papers in ⓘ
-
- Pluripotent Stem Cells Research 4
- Wnt/β-catenin signaling in development and cancer 3
- RNA Research and Splicing 3
- CRISPR and Genetic Engineering 3
- Epigenetics and DNA Methylation 2
-
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 7
- Co-authors
- Jiuhong Kang (13 shared papers)Xudong Guo (12 shared papers)Guiying Wang (7 shared papers)Dan Ye (3 shared papers)Jianmin Wang (2 shared papers)Qidong Liu (2 shared papers)Xiheng Hu (1 shared paper)Zhi Luo (1 shared paper)
- Journals
- Stem Cells (4 papers)PLoS ONE (3 papers)Oncotarget (2 papers)Biogerontology (1 paper)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Chenqi Lu
28 papers receiving 614 citations
Peers
Comparison fields: 5 of 75
- Cancer Research 230
- Molecular Biology 471
- Aging 5
- Oncology 54
- Immunology 38
Countries citing papers authored by Chenqi Lu
This map shows the geographic impact of Chenqi Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenqi Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenqi Lu more than expected).
Fields of papers citing papers by Chenqi Lu
This network shows the impact of papers produced by Chenqi Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenqi Lu. The network helps show where Chenqi Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chenqi Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 141 | |
| 2 | 2018 | 72 | |
| 3 | 2007 | 62 | |
| 4 | 2013 | 34 | |
| 5 | 2017 | 33 | |
| 6 | RNAi-mediated silencing of NOX4 inhibited the invasion of gastric cancer cells through JAK2/STAT3 signaling. | 2017 | 32 |
| 7 | 2008 | 30 | |
| 8 | 2017 | 26 | |
| 9 | 2012 | 23 | |
| 10 | 2012 | 22 | |
| 11 | 2021 | 18 | |
| 12 | 2017 | 17 | |
| 13 | 2020 | 17 | |
| 14 | 2010 | 11 | |
| 15 | 2020 | 11 | |
| 16 | 2024 | 11 | |
| 17 | 2017 | 11 | |
| 18 | 2019 | 10 | |
| 19 | 2020 | 10 | |
| 20 | 2022 | 7 |
About Chenqi Lu
Chenqi Lu is a scholar working on Molecular Biology, Cancer Research, Oncology, Genetics and Surgery, having authored 28 papers that have together received 622 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (7 papers), Pluripotent Stem Cells Research (4 papers), Wnt/β-catenin signaling in development and cancer (3 papers), RNA Research and Splicing (3 papers), CRISPR and Genetic Engineering (3 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (230 citations), Molecular Biology (471 citations), Aging (5 citations), Oncology (54 citations) and Immunology (38 citations). Chenqi Lu has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Jiuhong Kang, Xudong Guo, Guiying Wang, Dan Ye, Jianmin Wang, Qidong Liu, Xiheng Hu, Zhi Luo, Guoyan Wang and Xiaohua Hu. Their work appears in journals such as Stem Cells, PLoS ONE, Oncotarget, Biogerontology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.